These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34913547)

  • 1. Golimumab, as an alternative treatment in patients with coexisting hidradenitis suppurativa and arthritis after adalimumab failure: Report of two cases.
    Ramos FJM; Ruiz RG; Puchades AM
    Dermatol Ther; 2022 Mar; 35(3):e15266. PubMed ID: 34913547
    [No Abstract]   [Full Text] [Related]  

  • 2. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
    Yen CF; Huang YH; Chi CC
    Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.
    Zhao CY; Fernández-Peñas P
    Australas J Dermatol; 2018 Nov; 59(4):e297-e298. PubMed ID: 29672833
    [No Abstract]   [Full Text] [Related]  

  • 4. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
    Moul DK; Korman NJ
    Arch Dermatol; 2006 Sep; 142(9):1110-2. PubMed ID: 16982997
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab.
    Arakawa H; Adachi T; Kobayashi Y; Inazumi T
    J Dermatol; 2023 Jan; 50(1):e22-e23. PubMed ID: 36074661
    [No Abstract]   [Full Text] [Related]  

  • 7. Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure.
    Melendez-Gonzalez MDM; Hamad J; Sayed C
    J Invest Dermatol; 2021 Dec; 141(12):2975-2979. PubMed ID: 34097922
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

  • 9. Hidradenitis suppurativa and adalimumab in the COVID-19 era.
    Marzano AV; Moltrasio C; Genovese G; Muratori S; Dapavo P; Fabbrocini G; Patrizi A; Sechi A; Micali G; Pellegrino M; Gisondi P; Dini V; Bianchi L; Fania L; Offidani A; Prignano F; Atzori L; Miraglia E; Cannavò SP; Bettoli V; Stingeni L; Balestri R; Venturini M; Peris K
    Eur J Dermatol; 2020 Dec; 30(6):748-749. PubMed ID: 33337329
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
    Cline A; Pichardo RO
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ixekizumab in hidradenitis suppurativa in a psoriatic patient.
    Odorici G; Pellacani G; Conti A
    G Ital Dermatol Venereol; 2020 Dec; 155(6):788-789. PubMed ID: 30636397
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
    Moyano B; Clemente A; Marín-Jiménez I; Martorell A
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Certolizumab pegol as an alternative treatment in patients with coexisting hidradenitis suppurativa and other inflammatory immune-mediated diseases: Report of two cases.
    Melgosa Ramos FJ; García Ruiz R; Mateu Puchades A
    Dermatol Ther; 2022 May; 35(5):e15401. PubMed ID: 35199899
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab.
    Scheinfeld N
    J Am Acad Dermatol; 2006 Jul; 55(1):163-4. PubMed ID: 16781316
    [No Abstract]   [Full Text] [Related]  

  • 18. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
    Bassas-Vila J; González Lama Y
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.
    Repetto F; Roccuzzo G; Burzi L; Mastorino L; Dapavo P; Quaglino P; Ribero S
    Acta Derm Venereol; 2023 Apr; 103():adv5278. PubMed ID: 37073963
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic therapy: a boon for hidradenitis suppurativa-like lesions complicating naevus comedonicus in a prepubertal child.
    Sahu P; Aggarwal P; Dayal S; Kumar Jain V
    Clin Exp Dermatol; 2019 Apr; 44(3):322-324. PubMed ID: 29888492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.